TREATMENT OF TYPE 2 DIABETES MELLITUS WITH GLP-1 RECEPTOR AGONISTS, CHRONIC KIDNEY DISEASE AND INFLUENCE ON CARDIOVASCULAR RISK. TJS 2025, 23 (Supplement 1), 6. https://doi.org/10.15547/tjs.2025.s.01.004.